Tumour immunotherapy: the adjuvant treatment of the21st century?
- 30 June 2000
- journal article
- review article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 26 (4), 418-424
- https://doi.org/10.1053/ejso.1999.0908
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinomaCancer Immunology, Immunotherapy, 1999
- Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: Implications for the mechanism behind anti-tumor responsesInternational Journal of Cancer, 1998
- Regulation of adaptive immunity by natural killer cellsImmunologic Research, 1998
- Future perspectives in specific immunotherapy of melanomaEuropean Journal Of Cancer, 1998
- Dendritic cells and the control of immunityNature, 1998
- RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLSAnnual Review of Immunology, 1996
- Identification of the Genes Encoding Cancer Antigens: Implications for Cancer ImmunotherapyAdvances in Cancer Research, 1996
- Antibodies against p53 are associated with poor prognosis of colorectal cancerBritish Journal of Cancer, 1995
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994
- The Concept of Immunological SurveillancePublished by S. Karger AG ,1969